Maxigen Biotech Inc. (1783.TW) TAI

42.70

-0.25(-0.58%)

Updated at August 19 01:30PM

Currency In TWD

Valuation

Market Cap4.36B
Enterprise Value3.72B
P/E Ratio18.14
PEG Ratio1.84
Price/Sales Ratio5.23
Price/Book Ratio2.56
Enterprise/Revenue4.27
Enterprise/EBITDA13.03

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterMarch 31, 2025

Profitability

Profit Margin0.29
Operating Margin0.28

Management Effectiveness

Return On Assets0.12
Return On Equity0.15

Income Statement

Revenue680.65M
Revenue/Share8.23
Gross Profit483.33M
EBITDA221.4M
Net Income190.17M
Diluted EPS2.12

Balance Sheet

Total Cash704.38M
Total Cash/Share7.93
Total Debt0
Total Debt/Equity0
Current Ratio4.18
Book Value Per Share16.64

Price History

52-Week Change-2.63
52-Week High55
52-Week Low35.55
Moving Average 50 Days44.08
Moving Average 200 Days45.61

Statistics

Average Volume62,425
Shares Outstanding89.68M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor21:20
Last Split DateSeptember 07, 2023